YKL083W Antibody

What is YKL083W and why are antibodies against it used in research?

YKL083W is a genetic locus in Saccharomyces cerevisiae (baker's yeast) that is classified as a dubious open reading frame (ORF). Current experimental and comparative sequence data suggest it is unlikely to encode a functional protein, which makes it an interesting research target for studying genome organization. The locus partially overlaps with the verified essential gene RRP14, creating an interesting genomic architecture for study . Antibodies against YKL083W are primarily used in basic yeast genetics research, protein localization studies, and as controls in certain experimental conditions where dubious ORFs are used as reference points. Despite its classification as dubious, experimental evidence from phenotypic screens suggests the locus has measurable effects on yeast growth under various conditions .

What types of YKL083W antibodies are available for research?

Based on current information, researchers can access polyclonal antibodies against YKL083W, such as rabbit anti-Saccharomyces cerevisiae YKL083W polyclonal antibodies . These antibodies are typically produced by immunizing rabbits with recombinant or synthetic peptides corresponding to regions of the putative YKL083W protein. Recombinant proteins of YKL083W are also available for researchers who wish to develop their own antibodies or use them as controls in experimental work . The specificities and applications of these antibodies should be carefully validated prior to use, especially given the dubious nature of the YKL083W ORF.

How should I interpret YKL083W phenotypic data in relation to antibody studies?

When using YKL083W antibodies, it's essential to consider the phenotypic data available for this genomic locus. Phenotypic screens show varying normalized phenotypic values (NPVs) for YKL083W under different experimental conditions. For instance, in glucose limitation, YKL083W deletion shows a -2.82 NPV (12.50 percentile), suggesting significant growth defects . In contrast, when exposed to certain compounds like 2-amino-3-methylimidazo[4,5-f] quinoline in the presence of human CYP1A2 and NAT2 expression, it shows a positive NPV of 1.42 (100th percentile) . These phenotypic responses should inform experimental design when using YKL083W antibodies, particularly for localization studies or when attempting to correlate antibody staining patterns with functional outcomes. Consider these phenotypic data points as contextual information that helps interpret antibody-based observations.

What validation methods should I use to verify YKL083W antibody specificity?

Validating YKL083W antibody specificity is particularly critical given its status as a dubious ORF. A comprehensive validation approach should include:

• Knockout (KO) controls: Test the antibody in YKL083W deletion strains to confirm signal disappearance, similar to the approach used by YCharOS for antibody characterization .

• Multi-application testing: Validate the antibody across different applications including immunoblotting, immunoprecipitation, and immunofluorescence to ensure consistent results .

• Side-by-side comparison: If multiple YKL083W antibodies are available, compare them under identical conditions to identify the most specific option .

• Cross-reactivity assessment: Test against RRP14 protein (which overlaps with YKL083W) to ensure the antibody doesn't cross-react with this functionally important protein .

• Epitope mapping: Determine which region of the putative YKL083W protein the antibody recognizes, especially important given its dubious status.

Document all validation data systematically, as antibody specificity issues contribute significantly to research reproducibility problems, with an estimated $1 billion wasted annually on non-specific antibodies .

How can I address potential cross-reactivity with the overlapping RRP14 gene?

Addressing cross-reactivity between YKL083W antibodies and RRP14 requires a systematic approach:

• Epitope selection: When developing or selecting antibodies, choose epitopes unique to YKL083W that don't overlap with RRP14 coding regions .

• Comparative immunoblotting: Perform western blots using both YKL083W and RRP14 antibodies on the same samples to identify potential cross-reactivity patterns.

• Absorption controls: Pre-absorb the YKL083W antibody with recombinant RRP14 protein to remove potentially cross-reactive antibodies.

• Genetic controls: Use strains with modified RRP14 expression (conditional mutants, since RRP14 is essential) to determine if YKL083W antibody signals change correspondingly.

• Mass spectrometry validation: Perform immunoprecipitation followed by mass spectrometry to identify all proteins captured by the YKL083W antibody, checking specifically for RRP14 peptides.

This approach is particularly important because RRP14 is an essential gene, and misattribution of signals could lead to significant experimental misinterpretations and irreproducible results.

How should I incorporate YKL083W antibodies into repositories and search engines?

When submitting YKL083W antibody data to repositories or using search engines to find appropriate antibodies, consider these methodological approaches:

• Standardized characterization data: Provide comprehensive specificity data following standardized platforms like those used by YCharOS, which evaluates antibodies across multiple applications .

• Repository selection: Submit validation data to repositories appropriate for yeast research and dubious ORF studies, ensuring your data includes knockout controls and multiple application testing .

• Application-specific repositories: Consider submitting to both general antibody repositories and application-specific ones depending on your validation method (western blot, immunofluorescence, etc.) .

• Search strategy: When searching for existing YKL083W antibodies, use multiple search engines rather than relying on a single source, as coverage varies significantly between platforms .

• Data transparency: Include all negative results and cross-reactivity data in your submissions, as this information is crucial for other researchers working with potentially problematic targets like dubious ORFs .

Following these practices enhances research reproducibility and contributes to community knowledge about this challenging target.

What are the optimal conditions for using YKL083W antibodies in immunoblotting?

Optimizing YKL083W antibodies for immunoblotting requires careful consideration of several factors:

• Sample preparation: For yeast samples, use spheroplasting followed by gentle lysis to preserve protein structure. Standard protocols using glass beads or enzymatic digestion (zymolyase treatment) are recommended.

• Protein loading: Load 25-50 μg of total protein per lane, with both wild-type and YKL083W deletion strains as controls .

• Blocking conditions: Use 5% non-fat dry milk in TBST (Tris-buffered saline with 0.1% Tween-20) for 1 hour at room temperature to minimize background.

• Antibody dilution: Start with a 1:1000 dilution of primary antibody and optimize based on signal-to-noise ratio. Incubate overnight at 4°C for best results.

• Detection system: HRP-conjugated secondary antibodies with enhanced chemiluminescence typically provide adequate sensitivity for YKL083W detection.

• Controls: Always include recombinant YKL083W protein as a positive control and samples from YKL083W deletion strains as negative controls.

• Expected results: Since YKL083W is a dubious ORF, signals should be interpreted cautiously. Verify any bands at unexpected molecular weights through additional experiments.

Ensure consistent sample preparation across experiments to generate reproducible results, particularly important when working with potentially problematic targets like dubious ORFs.

How can I use YKL083W antibodies to study phenotype-genotype relationships in yeast?

Using YKL083W antibodies to investigate phenotype-genotype relationships requires a systematic experimental approach:

• Condition-specific expression analysis: Apply YKL083W antibodies in immunoblotting to quantify potential expression changes under conditions where significant phenotypic effects have been observed, such as glucose limitation (NPV: -2.82), phosphate limitation (NPV: -2.80), or sulfate limitation (NPV: -2.44) .

• Localization studies: Use immunofluorescence with validated YKL083W antibodies to determine if any detectable protein localizes differently under conditions that produce different phenotypic outcomes.

• Correlation analysis: Systematically correlate antibody signal intensity (by western blot or immunofluorescence) with phenotypic measurement data across multiple conditions to identify potential relationships.

• Co-immunoprecipitation: Apply YKL083W antibodies in co-IP experiments to identify potential interacting partners that might explain phenotypic effects, particularly focusing on interactions with RRP14 or related factors .

• Time-course studies: Use antibodies to track potential expression changes over time following environmental shifts that trigger phenotypic responses.

This methodological framework helps determine whether phenotypic effects associated with YKL083W are direct (due to the locus itself) or indirect (due to effects on the overlapping RRP14 gene or other mechanisms).

How should I interpret YKL083W antibody signals given its status as a dubious ORF?

Interpreting YKL083W antibody signals requires sophisticated analytical approaches given its classification as a dubious ORF:

• Signal verification hierarchy: Establish a multi-level verification system where antibody signals are only considered valid when confirmed across multiple detection methods (western blot, immunofluorescence, mass spectrometry).

• Genomic context analysis: Always analyze signals in the context of the genomic overlap with RRP14 . Compare YKL083W antibody signals with RRP14 detection patterns to identify potential artifacts.

• Transcriptional analysis correlation: Correlate antibody signals with RNA-seq or microarray data to determine if detected proteins correspond to transcribed regions.

• Alternative translation product consideration: Evaluate the possibility that YKL083W antibodies might detect non-canonical translation products, including those from alternative reading frames or truncated products.

• Post-translational modification analysis: Use phospho-specific or other modification-specific detection methods alongside standard antibodies to determine if any detected signal represents a modified form of a protein.

This nuanced interpretive framework acknowledges the complex reality of genomic organization, where even "dubious" regions may have functional relevance through mechanisms not immediately apparent from sequence analysis alone.

What role can YKL083W antibodies play in studying antisense transcription and genomic overlap?

YKL083W antibodies can serve as valuable tools for investigating the complex phenomena of antisense transcription and genomic overlap:

• Bidirectional detection: Use strand-specific methods alongside antibody detection to determine if protein signals correspond to sense, antisense, or bidirectional transcription.

• Overlap interaction studies: Apply YKL083W antibodies in conjunction with RRP14 antibodies to investigate whether protein products from overlapping genes physically interact or mutually regulate each other's expression .

• Regulatory element mapping: Combine chromatin immunoprecipitation (if YKL083W encodes any DNA-binding elements) with antibody detection to map potential regulatory interactions.

• Translation initiation mapping: Use ribosome profiling data alongside antibody detection to determine precise translation initiation sites and their relationship to detected protein signals.

• Evolutionary conservation analysis: Compare antibody detection patterns across closely related yeast species to identify conservation patterns that might suggest functional relevance despite "dubious" classification.

This methodological approach helps uncover the functional significance of complex genomic organizations where overlapping genes, antisense transcription, and non-canonical translation events may play important biological roles not obvious from primary sequence analysis.

How can YKL083W antibodies contribute to understanding the functional genomics of "dubious" ORFs?

YKL083W antibodies can serve as instrumental tools in the broader investigation of dubious ORFs:

• Systematic comparative analysis: Create a standardized pipeline using YKL083W antibodies as a model case for systematically studying other dubious ORFs in yeast. Compare detection patterns, localization, and condition-specific expression.

• Integration with phenomic data: Correlate antibody detection patterns with the extensive phenotypic data available for YKL083W and other dubious ORFs to identify functional patterns . For instance, analyze whether the negative NPVs under nutrient limitation (-2.82 for glucose limitation) correlate with detectable protein levels.

• Mechanistic studies: Use immunoprecipitation with YKL083W antibodies followed by RNA sequencing to identify potentially associated RNAs that might explain the phenotypic effects observed in screens.

• Regulatory network mapping: Apply systematic protein-protein interaction studies using YKL083W antibodies to determine if dubious ORFs participate in detectable regulatory networks.

• Stress response profiling: Analyze YKL083W protein detection patterns under diverse stress conditions, particularly those showing significant phenotypic effects like nutrient limitation, to establish potential functional roles in stress response.

This comprehensive approach transforms YKL083W antibodies from simple detection reagents into powerful tools for answering fundamental questions about genome organization and the functional relevance of supposedly non-functional genomic elements.

What are the most common technical issues with YKL083W antibodies and how can I address them?

Researchers frequently encounter several technical challenges when working with YKL083W antibodies:

• Background signal: High background is common due to potential cross-reactivity. Solution: Implement more stringent blocking (5% BSA instead of milk), increase washing steps (5x 5-minute washes), and optimize antibody dilutions through systematic titration experiments.

• Inconsistent detection: Given the dubious nature of YKL083W, detection may vary between experiments. Solution: Standardize protocols rigorously, prepare larger batches of lysates for multiple experiments, and include recombinant YKL083W protein as a positive control in every experiment .

• Cross-reactivity with RRP14: Overlapping genomic organization may cause signal confusion. Solution: Always run RRP14 detection in parallel, preferably on the same blot after stripping, to directly compare signal patterns .

• Epitope masking: Potential post-translational modifications might block antibody binding. Solution: Test multiple antibodies recognizing different epitopes, and consider sample treatments that remove modifications (phosphatases, deglycosylation enzymes).

• Strain-specific variations: Differences between laboratory strains may affect detection. Solution: Validate antibodies across multiple yeast strain backgrounds, always including proper positive and negative controls for each background.

Systematic documentation of optimization steps will help establish reliable protocols for this challenging target.

How do I design experimental controls specific for YKL083W antibody research?

Designing appropriate controls for YKL083W antibody experiments requires special consideration:

• Genetic knockout controls: Include YKL083W deletion strains as negative controls, recognizing that complete deletion may affect the overlapping RRP14 gene . Consider using strains with minimal disruption of YKL083W that preserve RRP14 function.

• Epitope competition: Pre-incubate antibodies with excess recombinant YKL083W protein to demonstrate binding specificity . The signal should disappear or significantly diminish in properly controlled experiments.

• Antibody isotype controls: Include irrelevant antibodies of the same isotype and concentration to control for non-specific binding, particularly important for immunofluorescence applications.

• Expression system controls: When using antibodies against tagged versions, include both untagged strains and alternative tag locations to control for tag-specific artifacts.

• Cross-species controls: Test antibodies against samples from closely related yeast species where YKL083W is not conserved , which should show no signal if the antibody is specific.

• RNA-protein correlation: Correlate protein detection with RNA expression using RT-PCR or RNA-seq to validate whether detected proteins correspond to actively transcribed regions.

This comprehensive control strategy helps distinguish genuine signals from artifacts, particularly important when studying genomic elements of uncertain function.

What is the recommended protocol for using YKL083W antibodies in immunoprecipitation studies?

For successful immunoprecipitation using YKL083W antibodies, follow this detailed protocol:

• Sample preparation:

  • Harvest 50 ml of yeast culture at OD600 ~0.8

  • Wash cells twice with cold PBS

  • Resuspend in 500 μl lysis buffer (50 mM HEPES pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% Na-deoxycholate, protease inhibitor cocktail)

  • Lyse using glass beads (5 cycles of 1 min vortexing, 1 min on ice)

  • Clarify lysate by centrifugation (13,000g, 15 min, 4°C)

• Antibody binding:

  • Pre-clear lysate with 50 μl Protein A/G beads for 1 hour at 4°C

  • Remove beads by centrifugation

  • Incubate 400 μl cleared lysate with 2-5 μg YKL083W antibody overnight at 4°C with gentle rotation

• Immunoprecipitation:

  • Add 50 μl pre-washed Protein A/G beads

  • Incubate 4 hours at 4°C with gentle rotation

  • Wash beads 5 times with wash buffer (lysis buffer with 300 mM NaCl)

  • Elute bound proteins with 50 μl SDS sample buffer (95°C, 5 min)

• Controls and validation:

  • Always include a negative control using non-specific IgG

  • Include input, unbound, and IP samples in subsequent analyses

  • Verify specificity through western blotting with a different YKL083W antibody

  • Consider mass spectrometry analysis of eluates to identify all co-precipitated proteins

• Data analysis:

  • Quantify band intensities relative to input

  • Compare with RRP14 immunoprecipitation patterns to identify potential overlaps

  • Document all parameters that affect IP efficiency for protocol optimization

This detailed protocol accounts for the challenges specific to studying dubious ORFs and provides a framework for reproducible immunoprecipitation experiments.